01 10BDSI
01 109655843
01 10Blank
01 10Y
01 102027-07-23
Patent Expiration Date : 2027-07-23
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207932
Patent Use Code : U-1556
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-2017
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207932
Patent Use Code : U-1556
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207932
Patent Use Code : U-1556
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207932
Patent Use Code : U-1556
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-2017
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207932
Patent Use Code : U-1556
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207932
Patent Use Code : U-1556
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207932
Patent Use Code : U-1556
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-2017
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-07-23
LOOKING FOR A SUPPLIER?
Market Place
